{
    "Trade/Device Name(s)": [
        "On-Call Plus Blood Glucose Monitoring System",
        "On-Call Plus Blood Glucose Meter",
        "On-Call Plus Blood Glucose Test Strips",
        "On-Call Plus Glucose Control Solution",
        "On-Call Plus Lancets",
        "On-Call Plus Lancing Device"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K090057",
    "Predicate Device Reference 510(k) Number(s)": [
        "K002134"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX",
        "FMK"
    ],
    "Summary Letter Date": "January 07, 2009",
    "Summary Letter Received Date": "January 08, 2009",
    "Submission Date": "January 07, 2009",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660",
        "21CFR878.4800"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single analyte control",
        "Lancet, Blood"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "On-Call Plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical enzymatic assay",
        "Amperometric detection"
    ],
    "Methodologies": [
        "Glucose oxidase biosensor"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Lancets",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for On-Call Plus Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using electrochemical enzymatic technology",
    "Indications for Use Summary": "Quantitative detection of glucose in capillary whole blood from fingertip, forearm, and/or palm by people with diabetes at home and by healthcare professionals to aid in monitoring effectiveness of diabetes control programs; not for diagnosis/screening of diabetes or use on neonates",
    "fda_folder": "Clinical Chemistry"
}